EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications—2023 Diabetes , Diabetes Care , and Diabetologia Expert Forum

Mariana Byndloss iD, Suzanne Devkota iD, Frank Duca iD, Jan Hendrik Niess iD, Max Nieuwdorp iD, Marju Orho-Melander iD, Yolanda Sanz iD, Valentina Tremaroli iD, Liping Zhao iD

Diabetes · 01.09.2024 · 73 (9) · 1391-1410

DOI: 10.2337/dbi24-0028 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes, online erschienen am 24.06.2024. Verfasst von Mariana Byndloss und 8 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt University Medical Center, Nashville, TN. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 237 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Spanish Ministry of Science, Innovation and Universities MICIU/AEI, ZONMW-VICI, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This article summarizes the state of the science on the role of the gut microbiota (GM) in diabetes from a recent international expert forum organized by Diabetes, Diabetes Care, and Diabetologia, which was held at the European Association for the Study of Diabetes 2023 Annual Meeting in Hamburg, Germany. Forum participants included clinicians and basic scientists who are leading investigators in the field of the intestinal microbiome and metabolism. Their conclusions were as follows: 1) the GM may be involved in the pathophysiology of type 2 diabetes, as microbially produced metabolites associate both positively and negatively with the disease, and mechanistic links of GM functions (e.g., genes for butyrate production) with glucose metabolism have recently emerged through the use of Mendelian randomization in humans; 2) the highly individualized nature of the GM poses a major research obstacle, and large cohorts and a deep-sequencing metagenomic approach are required for robust assessments of associations and causation; 3) because single–time point sampling misses intraindividual GM dynamics, future studies with repeated measures within individuals are needed; and 4) much future research will be required to determine the applicability of this expanding knowledge to diabetes diagnosis and treatment, and novel technologies and improved computational tools will be important to achieve this goal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDiabetes Mellitus, Type 2HumansTranslational Research, Biomedical

Autor:innen und Institutionen

  • Vanderbilt University Medical Center, Nashville, TN.
  • Howard Hughes Medical Institute, Vanderbilt University Medical Center, Nashville, TN.
  • Human Microbiome Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA.
  • University of Arizona, Tucson, AZ.
  • Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Department of Gastroenterology and Hepatology, University Digestive Healthcare Center, Clarunis, Basel, Switzerland.

ORCID-Profile: Mariana Byndloss, Suzanne Devkota, Frank Duca, Jan Hendrik Niess, Max Nieuwdorp, Marju Orho-Melander, Yolanda Sanz, Valentina Tremaroli, Liping Zhao

Förderung

  • Spanish Ministry of Science, Innovation and Universities MICIU/AEI
  • ZONMW-VICI
  • NIEHS NIH HHS
  • Novo Nordisk Foundation
  • NIDDK NIH HHS
  • Severo Ochoa Center of Excellence
  • Swiss National Science Foundation (SNSF)
  • European Union’s Innovative Medicine Initiative

Zitieren

APA

Byndloss, M., Devkota, S., Duca, F., Niess, J. H., Nieuwdorp, M., Orho-Melander, M., Sanz, Y., Tremaroli, V., & Zhao, L. (2024). The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications—2023 Diabetes , Diabetes Care , and Diabetologia Expert Forum. Diabetes, 73(9), 1391-1410. https://doi.org/10.2337/dbi24-0028

Vancouver

Byndloss M, Devkota S, Duca F, Niess JH, Nieuwdorp M, Orho-Melander M, et al. The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications—2023 Diabetes , Diabetes Care , and Diabetologia Expert Forum. Diabetes. 2024;73(9):1391-1410. doi:10.2337/dbi24-0028

BibTeX
@article{Byndloss2024,
  author = {Byndloss, Mariana and Devkota, Suzanne and Duca, Frank and Niess, Jan Hendrik and Nieuwdorp, Max and Orho-Melander, Marju and Sanz, Yolanda and Tremaroli, Valentina and Zhao, Liping},
  title = {The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications—2023 Diabetes , Diabetes Care , and Diabetologia Expert Forum},
  journal = {Diabetes},
  year = {2024},
  volume = {73},
  number = {9},
  pages = {1391--1410},
  doi = {10.2337/dbi24-0028}
}
Kostenlos starten →